Breaking News

Recipharm To Provide Parenteral Veterinary Product

November 19, 2012

Development and manufacture to take place at Solna and Monts sites

Recipharm has entered into a collaboration agreement with Vetcare for the development and manufacture of a parenteral veterinary product. Recipharm will develop the product at its site in Solna, Sweden and the commercial manufacture will take place at its site in Monts, France.
 
Maria Lundberg, general manager, Recipharm Pharmaceutical Development, said, "We are pleased to have entered into this collaboration with Vetcare. This project is perfectly suited to Recipharm as it allows us to demonstrate our expertise in formulation and analytical method development with a challenging formulation before performing technology transfer to commercial manufacturing.”
 
"Michel Saudemon, general manager of Recipharm in Monts, said, "This project is excellent news and is a perfect fit for our new smaller scale flexible manufacturing facility, which will come on line next year.”

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

blog comments powered by Disqus
  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments

  • Patent Law  and Contract Manufacturing

    Patent Law and Contract Manufacturing

    Beverly W. Lubit, Member of the Firm, Chiesa Shahinian & Giantomasi||September 8, 2016
    Analyzing the impact of The Medicines Co. vs. Hospira Inc. decision